PRESTA- Promoting Recovery after Stroke with Amantadine
Age
18 years - 99 years
Gender
All
participants needed
60
Location
1
Brief description of study
The research team aims to examine whether amantadine can help patients recover from stroke. This will be a blinded randomized clinical trial. We will randomize patients post-ischemic or hemorrhagic stroke either to the placebo arm or amantadine. Patients will be on study drug or placebo for 1 month but will be enrolled for 3 months total. At various time points they will be examined and fill out questionnaires to determine their level of stroke recovery.
Adult subjects within 24 hours to 3 weeks after an ischemic or hemorrhagic stroke, will be recruited from Penn Medicine's Emergency Department, inpatient and outpatient practices by the Stroke team.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: stroke,cardiac
-
Age: 18 years - 99 years
-
Gender: All
Updated on
04 Aug 2024.
Study ID: 849451
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
Please choose between Voice or SMS based delivery of verification code
or